Page 110 - MEMORIA_SEHH-FEHH_2023

MEMORIA ANUAL 2023
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
28th Congress of the EHA. EHA2023 Frankfurt & Virtual, Jun (8-11) (P878).
González-Calle V, Rodríguez-Otero P, Sureda A, De Arriba de La Fuente F, Reinoso Se-
gura M, Ribas P, González AP, González Montes Y, Oriol A, Martínez-López J, González
Pérez MS, Teodoro Hernández M, Sirvent Auzmendi M, Bladé J, Lahuerta Palacios JJ, San
Miguel J, Mateos MV.
• Prognostic value of positron emission tomography/computed tomography in re-
lapsed/refractory multiple myeloma patients treated with chimeric antigen receptor
T-cell therapy.
28th Congress of the EHA. EHA2023 Frankfurt & Virtual, Jun (8-11) (P887).
Tamariz-Amador LE, Alfonso-Piérola A, Huerga-Domínguez S, Panizo-Inoges M, Palacios-
Berraquero ML, Rifón Roca JJ, Villar-Fernández S, Marcos Jubilar M, Prósper F, Betech-
Antar V, San Miguel J, García-Velloso MJ, Rodríguez-Otero P.
• Real-world evidence of bisphosphonates for multiple myeloma.
28th Congress of the EHA. EHA2023 Frankfurt & Virtual, Jun (8-11) (P948).
López Muñoz MN, Hernández G, Alonso R, Sánchez Pina JM, Cuéllar C, Jiménez Ubieto
A, Parra E, Blanco A, Ramos G, Calbacho M, Ayala R, Martínez-López J.
• Impact of measurable residual disease (MRD) differences on progression-free sur-
vival (PFS): an aggregate data analysis from randomized clinical trials in multiple
myeloma (MM).
28th Congress of the EHA. EHA2023 Frankfurt & Virtual, Jun (8-11) (P951).
Paiva B, Zherniakova A, Núñez J, Rodríguez-Otero P, Shi Q, Munshi N, Durie B, San Mi-
guel J.
• A machine learning model for risk prediction in multiple myeloma progressing after
the first line of therapy.
28th Congress of the EHA. EHA2023 Frankfurt & VIRTUAL, JUN (8-11) (P967).
Mosquera-Orgueira A, González Pérez MS, Díaz Arias JA, Mateos MV.
• Clinical Characteristics and Risk of Progression in Patients With Monoclonal Gam-
mopathy of Uncertain Significance (MGUS): Long‑Term. Experience in a Single Ter-
tiary Hospital.
11st Society of Hematologic Oncology (SOHO) Annual Meeting 2023. Hybrid event, 06-09
Sep 2023. (MM-341).
Alejo E, Puertas B, Agulló Biochemistry C, Alonso D, Rey-Búa B, García-Sanz R, Puig N,
Mateos MV, González-Calle V.
110